Leal Therapeutics Funding: $69M Raised, Series A (2025)
Leal Therapeutics is a Biotech company based in Worcester, null. It has raised $69M in total funding. Latest round: Series A.
Leal Therapeutics funding overview
Leal Therapeutics is a Biotech company based in Worcester, null. Leal Therapeutics has raised $69M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2025. The round record for Leal Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include SV Health Investors' Dementia Discovery Fund.
Leal Therapeutics at a glance
Total raised
$69M
Latest round
Series A
Latest round date
August 2025
Industry
Biotech
Headquarters
Worcester, null
Notable investors
SV Health Investors' Dementia Discovery Fund
Frequently asked about Leal Therapeutics funding
How much has Leal Therapeutics raised?
Leal Therapeutics has raised $69M in total disclosed funding across the rounds on record.
Who has invested in Leal Therapeutics?
SV Health Investors' Dementia Discovery Fund are named among the investors backing Leal Therapeutics.
What was the latest Leal Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2025.
Where is Leal Therapeutics based?
Leal Therapeutics is based in Worcester, null.
What sector does Leal Therapeutics operate in?
Leal Therapeutics is tracked under Biotech from Worcester, null, with $69M in disclosed funding.
When did Leal Therapeutics last raise?
The last disclosed Leal Therapeutics round closed in August 2025 at Series A.
Totals shown for Leal Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Worcester and the investors behind them below.
